Helping people in substance use treatment reduce tobacco harm
Evaluating a tobacco harm reduction strategy among clients enrolled in substance use disorder treatment
This study is looking at ways to help people who are getting treatment for substance use disorders quit smoking by encouraging them to switch from regular cigarettes to safer options like e-cigarettes, making it easier for them to improve their health while tackling both issues at the same time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-11192931 on NIH RePORTER |
What this research studies
This research investigates how to effectively reduce tobacco use among individuals undergoing treatment for substance use disorders. It focuses on implementing low-intensity harm reduction strategies that encourage smokers to switch from combustible cigarettes to less harmful alternatives, such as e-cigarettes. The approach aims to improve health outcomes for patients by addressing both their substance use and smoking habits simultaneously. By evaluating the effectiveness of these strategies, the research seeks to enhance the overall treatment experience for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals currently enrolled in substance use disorder treatment who also smoke cigarettes.
Not a fit: Patients who do not smoke or are not enrolled in substance use disorder treatment may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for patients by reducing tobacco-related illnesses among those in substance use disorder treatment.
How similar studies have performed: Previous research has shown that harm reduction strategies can be effective in improving health outcomes for smokers, particularly in populations with high rates of substance use.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Mcclure, Erin a — Medical University of South Carolina
- Study coordinator: Mcclure, Erin a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.